Spero Therapeutics (SPRO) Non Operating Income (2019 - 2026)
Spero Therapeutics' Non Operating Income came in at $374,000 for Q2 2026, down 49.7% from $744,000 a year earlier but up 11.6% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Non Operating Income (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Spero Therapeutics reported Non Operating Income of $1.62 million, down 58.4% year-over-year; for FY2025, it came in at $2.52 million, down 47.5% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $4.8 million in FY2024 (+22.2%), $3.92 million in FY2023, -$4.22 million in FY2022 and -$1.79 million in FY2021.
- The five-year range for quarterly Non Operating Income is -$2.62 million (Q1 2022) to $1.31 million (Q1 2024).
- Year-over-year, Non Operating Income has declined for six consecutive quarters, with an average decline of 34.1% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q3 2023 (growth of 491.2%), and the weakest in Q3 2021 (a decline of 96.4%).
- Business Quant data shows SPRO's Non Operating Income at $335,000 (Q1 2026), $376,000 (Q4 2025) and $534,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | 374,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 374,000.00 |
| Mar 31, 2026 | 335,000.00 |
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | 534,000.00 |
| Jun 30, 2025 | 744,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 940,000.00 |
| Jun 30, 2023 | 976,000.00 |
| Mar 31, 2023 | 961,000.00 |
| Dec 31, 2022 | 847,000.00 |
| Sep 30, 2022 | 159,000.00 |
| Jun 30, 2022 | -2.60 Mn |
| Mar 31, 2022 | -2.62 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | 3,000.00 |
API Access
Spero Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();